We noticed an increased number of patients diagnosed with colorectal cancer (CRC) in their 20s, 30s, and 40s. We analyzed all CRC patients aged < 50 at our institutions from 1972 to 2017 and found increasing trends as well as a propensity for more distal location-findings that are hypothesis generating, given the embryologic origin of these tumors. This finding may have implications for screening guidelines. Background: Recent trends have identified increasing number of young individuals with rectal and colon cancers. These individuals, who are younger than 50 years old, in most instances would not meet screening guidelines. We aimed to report the characteristics and trend of the rising proportion of young individuals being diagnosed with rectal and colon cancers at our institutions. Patients and Methods: This study included 3381 rectal and colon cancer patients from the Mayo Clinic cancer registry from 1972 to 2017 who were diagnosed with rectal or colon cancer and who were < 50 years old. Patient and cancer characteristics are described. The Cochran-Armitage trend test was used to see if the change in percentage diagnosed at age < 50 years had a significant trend over the years. A linear regression model was fit to estimate the percentage change per year when the trend was approximately linear. Results: The percentage of patients diagnosed with rectal or colon cancer in different age categories over the years showed a rising trend for individuals aged < 50. Most of these tumors were distal (rectum, left-sided colon, and rightsided colon were 49.8%, 28.8%, and 21.4%, respectively). This was more so for patients < 50 diagnosed with rectal cancer, which showed a linear increase at a rate of 0.26% per year (P < .001). Conclusion: Our study affirms the rising proportion of colorectal cancers found in young individuals, with a linear ongoing rise of rectal cancers in particular. This may have implications for the current screening recommendations for colorectal cancers, which are already being revised.
Introduction
Colorectal cancer (CRC) incidence patterns have been changing over the last few decades. With the advent of colonoscopy and other screening modalities, an overall declining trend of CRC has been observed, particularly in older populations. 1 However, for unclear reasons, a rise in CRC incidence has been reported in patients aged < 50 years. [1] [2] [3] Younger patients tend to present with more advanced disease, which may reflect different tumor biology. [3] [4] [5] [6] This alarming trend has led to some of the screening guidelines being revised to lower the age of screening from 50 years to 45 years. The goal of our study was to examine the trends and characteristics of young patients (age < 50 years) diagnosed with rectal and colon cancer. We also report their survival rates by both patient age and disease stage categories.
Patients and Methods

Study Design and Data Source
After obtaining institutional review board approval, we conducted a retrospective observational study of all CRC patients aged < 50 years evaluated from 1972 to 2017 at Mayo Clinic in the United States. Mayo Clinic is a 3-site (Minnesota, Florida, and Arizona), single-institution health care network. We included data of CRC patients captured from an institutional cancer registry from all 3 hospitals: Minnesota (from 1972), Florida (from 1986), and Arizona (from 1987). Cases were classified according to tumor origin. Tumors deemed to be originating from the appendix were excluded, and for the purposes of this analysis, rectosigmoid tumors were grouped into rectal tumors.
Statistical Analysis
Continuous variables were summarized as mean (standard deviation) and median (range), while categorical variables were reported as frequency (percentage). The Kaplan-Meier method was used to estimate overall survival and to draw Kaplan-Meier curves. Cumulative survival rates were compared between groups using the logrank test. The percentage of each age group was calculated against the total population diagnosed with CRC for each year. The Cochran-Armitage trend test was used to see if the change in percentage diagnosed patients aged < 50 had a significant trend over the years. The linear regression model was fit to estimate the percentage change per year when the trend was approximately linear.
All tests were 2 sided, with an a level set at .05 for statistical significance.
Results
This study included 3381 CRC patients from the Mayo Clinic cancer registry who were diagnosed at age < 50 years between 1972 and 2017. Median age at diagnosis was 41 years. The majority of patients were diagnosed with more distal tumors. The proportion of patients having cancer of rectum, left-sided colon, and right-sided colon were 49.8%, 28.8%, and 21.4%, respectively. Most of the patients had late-stage disease at the time of diagnosis. The proportion of patients diagnosed with stage 3 and 4 disease was 30.4% and 27.4%, respectively. Patient and cancer characteristics are summarized in Table 1 .
In order to compare the proportions of rectal and colon cancers in younger individuals, we also included patient data of individuals diagnosed age > 50 years in our analysis. This also allowed for comparison to recently reported trends and studies.
As noted in Supplemental Figures 1 and 2 in the online version, there is an overall rising trend of proportion of younger patients being diagnosed with rectal and colon cancers. This was particularly significant for rectal cancer, which appears to follow a linear trend. The percentage of patients < 50 diagnosed with rectal cancer increased at a rate of 0.26% per year (P < .001) (Figure 1 ). Although the percentage of patients < 50 diagnosed with colon cancer increased, it did not demonstrate a linear pattern (P ¼ .296) (Figure 2) .
The increasing trend of rectal cancer diagnoses began early and demonstrated a steeper rise than that of colon cancer. The Table 2 . The 5-year overall survival rate for patients < 30 years who were diagnosed was 68% (95% confidence interval, 62, 74), which was significantly better than that of patients diagnosed at ages 30 to 39 years and at 40 to 49 years (P ¼ .003). Kaplan-Meier survival curves by age category, as presented in Supplemental Figure 3 in the online version, also showed better overall survival for patients aged 29 compared to those aged 30 to 49 years. Kaplan-Meier survival curves by stage category are shown in Supplemental Figure 4 in the online version.
Discussion
Our analysis of the data from our 3-site Mayo Clinic cancer registry has 3 main findings. First, the data show and corroborate the increasing trend in percentage of CRC cases for populations aged < 50 years. Second, from a tumor biology perspective, these tumors in younger individuals are predominantly left-sided colon and rectal cancers. Finally, a higher proportion of younger individuals had advanced CRC.
Recently Siegel et al 7 studied 490,305 CRC patients from 9
Surveillance, Epidemiology, and End Results (SEER) registries; they were among of the first to report the rise in CRC incidence in a younger population. We performed our analysis similarly and had similar results. Tawadros et al  3 did a retrospective study on 38,351 rectal cancer patients diagnosed between 1980 to 2010 and also reported that the incidence of rectal cancer increased in a young population (aged 20-39 years) since 1980 compared to older populations (aged > 40 years). The aforementioned studies included data from national databases, and reported that the risk and incidence of rectal cancer have quadrupled over the years. Our study included patient cohorts from affiliated academic centers and revealed similar trends, with an estimated increase of rectal cancer cases occurring in young patients at a rate of 0.26% per year (P < .001). Another study in 2017 reported a rise of young-onset CRC in an Australian population, with an estimated annual percentage change of 3.0 (95% confidence interval, 0.7, 5.5) in CRC incidence in young individuals aged 15 to 39 diagnosed from 1982 to 2007. 8 For the purposes of our study, we defined age < 50 years as young, given that this was the age when initial screening was recommended for average-risk individuals before a recent update in the screening guidelines. It is important to note that different studies use different age cutoffs (age < 55 in some and < 40 in others). 3, [7] [8] [9] The reason for this increase in CRC in young individuals is not entirely clear. Most of these cases are sporadic rather than hereditary. 10 Previously hereditary factors were largely considered to be the main influence resulting in CRC in young patients. 11, 12 However, several social and behavioral risk factors, such as alcohol consumption, 13 tobacco smoking, 14-17 red meat intake, 13, 18, 19 and obesity, 13, 20, 21 have been found to be associated with CRC.
However, these do not fully explain the rise of CRC in young individuals. Because younger individuals are not routinely screened for CRC, this places them at an increased risk of being diagnosed only What is particularly intriguing to note is that we found that the majority of young individuals in our cohort developed cancer of leftsided colon or rectum. This propensity of left-sided colon and rectal cancers in the younger population has been described in some other studies. [25] [26] [27] A recent study of 739 CRC patients < 50 years showed that most had tumors of left side (83%) compared to right side (17%). 28 Studies have also shown that the tumors of rectum and left-sided colon are associated with increased survival compared to right-sided CRC, which is the result of the different embryologic origin of these parts of the gut. 29 We argue that these findings are more than hypothesis generating: younger individuals are at an increased risk of particularly rectal and left-sided colon cancers. This has implications for both screening modalities (eg, sigmoidoscopy) and treatment strategies. Screening colonoscopy has revolutionized the management of CRC and has significantly improved survival. Our results show decreasing trends of CRC in populations aged > 50. Historically, colonoscopy was introduced by Overholt 30 in the United States and Niwa et al in Japan in early 1970s, 31 but it was not included in the screening guidelines until 1997, when results of few randomized controlled trials became available. [32] [33] [34] It became truly popular after the diagnosis of President Ronald Reagan with CRC in 1985 and the so-called Katie Couric Effect in 2000, when patients began to seek screening for CRC. 31 Our analysis coincides with this background because we found a decline of CRC in older individuals in the last 2 decades, when colonoscopy was instituted in screening guidelines. Recently the American Cancer Society updated the screening guidelines and recommended to lower the start age of screening from age 50 to 45 for the general population. 35 However, these are qualified recommendations at this point. Studies like ours, however, are backing up the overall push to move the screening to an earlier age.
It is important to note that our analysis showed better overall survival in patients aged < 30 years compared to 30 years. This is despite of the fact that the majority of younger patients in our analysis presented with later stages of disease. This is not surprising because younger individuals would tend to do better and would tolerate chemotherapy and treatment better. However, studies have reported controversial results in this regard. McKay et al 36 studied 2086 patients diagnosed with CRC in the province of Manitoba, Canada, and reported that 67.1% of patients aged < 45 years had better 5-year overall survival compared to older patients aged 45 to 79 (54.7%) and 80 (33.4%). Wang et al 37 studied 509,934 CRC patients from Taiwanese population and reported that individuals aged 40 had poor overall survival compared to those aged 41 to 70. Our study has several limitations, given the inherent retrospective nature and selection of patients, belonging mainly to 3 US states who presented to an academic institution for their care. Patients from Mayo Clinic cancer registry are more likely to be referred from other medical centers, which increases their probability of having advanced or complex disease at the time of diagnosis. However, our findings and analysis showing similar trends as seen in other recent studies, along with the finding of left-sided colon and rectal cancers in particular constituting the bulk of these cancers, is more than hypothesis generating. This study provides an opportunity to build on the current screening guidelines and come up with novel therapies for the rising proportion of young individuals with CRC, as disease in this population may reflect a different biology.
Conclusion
Using data from the Mayo Clinic cancer registry, this study corroborates the recently noted rising trend in the proportion of younger individuals being diagnosed with rectal and colon cancer. Of particular note is the propensity for distal tumors (rectum and left-sided colon cancers).
Clinical Practice Points
Recent trends showed a rise in the proportions of rectal and colon cancer in individuals aged < 50 years. This led to an update of screening guidelines by the American Cancer Society, which lowered age to initiate CRC screening from 50 years to 45 years for average-risk individuals. However, the update is a qualified recommendation, not a strong recommendation, at this point. Our study showed increasing trends of CRC in individuals aged < 50 and corroborated other studies as well as a recent update in the screening guidelines. Young-onset CRC has a greater tendency for distal location (rectum and left-side colon) compared to right-sided colon. 
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